Merck & Co., Inc. Reclassification from AOCI, Current Period, Tax
Merck & Co., Inc. (MRK) reported Reclassification from AOCI, Current Period, Tax of $14.00 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-03.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ReclassificationFromAociCurrentPeriodTax · last filed 2023-11-03
- Merck & Co., Inc. reclassification from aoci, current period, tax for the quarter ending 2023-09-30 was $14.00M, a 36.36% decline year-over-year.
- Merck & Co., Inc. reclassification from aoci, current period, tax for the quarter ending 2023-06-30 was $6.00M, a 20.00% increase year-over-year.
- Merck & Co., Inc. reclassification from aoci, current period, tax for the quarter ending 2023-03-31 was $23.00M, a 1050.00% increase year-over-year.
- Merck & Co., Inc. reclassification from aoci, current period, tax for the quarter ending 2022-12-31 was $58.00M.
- Merck & Co., Inc. reclassification from aoci, current period, tax for fiscal 2022 was $87.00M.
- Merck & Co., Inc. reclassification from aoci, current period, tax for fiscal 2021 was -$142.00M.
- Merck & Co., Inc. reclassification from aoci, current period, tax for fiscal 2020 was -$72.00M, a 280.00% decline from fiscal 2019.
- Merck & Co., Inc. reclassification from aoci, current period, tax for fiscal 2019 was $40.00M.
| Period end | Reclassification from AOCI, Current Period, Tax 3 month | Reclassification from AOCI, Current Period, Tax 6 month | Reclassification from AOCI, Current Period, Tax 9 month | Reclassification from AOCI, Current Period, Tax 12 month | Reclassification from AOCI, Current Period, Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2023-09-30 | $14.00M 10-Q · filed 2023-11-03 | $20.00M derived: sum of 2 quarters · filed 2023-11-03 | $43.00M 10-Q · filed 2023-11-03 | $101.00M derived: sum of 4 quarters · filed 2023-11-03 | |
| 2023-06-30 | $6.00M 10-Q · filed 2023-08-07 | $29.00M 10-Q · filed 2023-08-07 | $87.00M derived: sum of 3 quarters · filed 2023-08-07 | $109.00M derived: sum of 4 quarters · filed 2023-11-03 | |
| 2023-03-31 | $23.00M 10-Q · filed 2023-05-05 | $81.00M derived: sum of 2 quarters · filed 2023-05-05 | $103.00M derived: sum of 3 quarters · filed 2023-11-03 | $108.00M derived: sum of 4 quarters · filed 2023-11-03 | |
| 2022-12-31 | $58.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $80.00M derived: sum of 2 quarters · filed 2023-11-03 | $85.00M derived: sum of 3 quarters · filed 2023-11-03 | $87.00M 10-K · filed 2023-02-24 | |
| 2022-09-30 | $22.00M 10-Q · filed 2023-11-03 | $27.00M derived: sum of 2 quarters · filed 2023-11-03 | $29.00M 10-Q · filed 2023-11-03 | -$25.00M derived: sum of 4 quarters · filed 2023-11-03 | |
| 2022-06-30 | $5.00M 10-Q · filed 2023-08-07 | $7.00M 10-Q · filed 2023-08-07 | -$47.00M derived: sum of 3 quarters · filed 2023-08-07 | -$77.00M derived: sum of 4 quarters · filed 2023-08-07 | |
| 2022-03-31 | $2.00M 10-Q · filed 2023-05-05 | -$52.00M derived: sum of 2 quarters · filed 2023-05-05 | -$82.00M derived: sum of 3 quarters · filed 2023-05-05 | -$116.00M derived: sum of 4 quarters · filed 2023-05-05 | |
| 2021-12-31 | -$54.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$84.00M derived: sum of 2 quarters · filed 2023-02-24 | -$118.00M derived: sum of 3 quarters · filed 2023-02-24 | -$142.00M 10-K · filed 2023-02-24 | -$100.00M 10-K · filed 2022-02-25 |
| 2021-09-30 | -$30.00M 10-Q · filed 2022-11-03 | -$64.00M derived: sum of 2 quarters · filed 2022-11-03 | -$88.00M 10-Q · filed 2022-11-03 | -$132.00M derived: sum of 4 quarters · filed 2023-02-24 | |
| 2021-06-30 | -$34.00M 10-Q · filed 2022-08-05 | -$58.00M 10-Q · filed 2022-08-05 | -$102.00M derived: sum of 3 quarters · filed 2023-02-24 | -$120.00M derived: sum of 4 quarters · filed 2023-02-24 | |
| 2021-03-31 | -$24.00M 10-Q · filed 2022-05-05 | -$68.00M derived: sum of 2 quarters · filed 2023-02-24 | -$86.00M derived: sum of 3 quarters · filed 2023-02-24 | -$92.00M derived: sum of 4 quarters · filed 2023-02-24 | |
| 2020-12-31 | -$44.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$62.00M derived: sum of 2 quarters · filed 2023-02-24 | -$68.00M derived: sum of 3 quarters · filed 2023-02-24 | -$72.00M 10-K · filed 2023-02-24 | -$63.00M 10-K · filed 2021-02-25 |
| 2020-09-30 | -$18.00M 10-Q · filed 2021-11-05 | -$24.00M derived: sum of 2 quarters · filed 2021-11-05 | -$28.00M 10-Q · filed 2021-11-05 | -$20.00M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | -$6.00M 10-Q · filed 2021-08-09 | -$10.00M 10-Q · filed 2021-08-09 | -$2.00M derived: sum of 3 quarters · filed 2022-02-25 | $11.00M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | -$4.00M 10-Q · filed 2021-05-05 | $4.00M derived: sum of 2 quarters · filed 2022-02-25 | $17.00M derived: sum of 3 quarters · filed 2022-02-25 | $30.00M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $21.00M derived: sum of 2 quarters · filed 2022-02-25 | $34.00M derived: sum of 3 quarters · filed 2022-02-25 | $40.00M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $13.00M 10-Q · filed 2020-11-05 | $26.00M derived: sum of 2 quarters · filed 2020-11-05 | $32.00M 10-Q · filed 2020-11-05 | $22.00M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $13.00M 10-Q · filed 2020-08-05 | $19.00M 10-Q · filed 2020-08-05 | $9.00M derived: sum of 3 quarters · filed 2021-02-25 | $1.00M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $6.00M 10-Q · filed 2020-05-06 | -$4.00M derived: sum of 2 quarters · filed 2021-02-25 | -$12.00M derived: sum of 3 quarters · filed 2021-02-25 | -$37.00M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | -$10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$18.00M derived: sum of 2 quarters · filed 2021-02-25 | -$43.00M derived: sum of 3 quarters · filed 2021-02-25 | -$69.00M 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$8.00M 10-Q · filed 2019-11-05 | -$33.00M derived: sum of 2 quarters · filed 2019-11-05 | -$59.00M 10-Q · filed 2019-11-05 | -$45.00M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-06-30 | -$25.00M 10-Q · filed 2019-08-06 | -$51.00M 10-Q · filed 2019-08-06 | -$37.00M derived: sum of 3 quarters · filed 2020-02-26 | -$31.00M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2018-03-31 | -$25.00M 10-Q · filed 2019-05-08 | -$12.00M derived: sum of 2 quarters · filed 2020-02-26 | -$6.00M derived: sum of 3 quarters · filed 2020-02-26 | $3.00M derived: sum of 4 quarters · filed 2020-02-26 | |
| 2017-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $19.00M derived: sum of 2 quarters · filed 2020-02-26 | $28.00M derived: sum of 3 quarters · filed 2020-02-26 | $75.00M 10-K · filed 2020-02-26 | |
| 2017-09-30 | $6.00M 10-Q · filed 2018-11-06 | $15.00M derived: sum of 2 quarters · filed 2018-11-06 | $62.00M 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $9.00M 10-Q · filed 2018-08-07 | $56.00M 10-Q · filed 2018-08-07 | |||
| 2017-03-31 | $47.00M 10-Q · filed 2018-05-08 | ||||
| 2016-09-30 | $17.00M 10-Q · filed 2016-11-07 | $42.00M derived: sum of 2 quarters · filed 2016-11-07 | $97.00M 10-Q · filed 2016-11-07 | $167.00M derived: sum of 4 quarters · filed 2016-11-07 | |
| 2016-06-30 | $25.00M 10-Q · filed 2016-08-08 | $80.00M 10-Q · filed 2016-08-08 | $150.00M derived: sum of 3 quarters · filed 2016-08-08 | $194.00M derived: sum of 4 quarters · filed 2016-11-07 | |
| 2016-03-31 | $55.00M 10-Q · filed 2016-05-09 | $125.00M derived: sum of 2 quarters · filed 2016-05-09 | $169.00M derived: sum of 3 quarters · filed 2016-11-07 | $221.00M derived: sum of 4 quarters · filed 2016-11-07 | |
| 2015-12-31 | $70.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $114.00M derived: sum of 2 quarters · filed 2016-11-07 | $166.00M derived: sum of 3 quarters · filed 2016-11-07 | $219.00M 10-K · filed 2016-02-26 | |
| 2015-09-30 | $44.00M 10-Q · filed 2016-11-07 | $96.00M derived: sum of 2 quarters · filed 2016-11-07 | $149.00M 10-Q · filed 2016-11-07 | $180.00M derived: sum of 4 quarters · filed 2016-11-07 | |
| 2015-06-30 | $52.00M 10-Q · filed 2016-08-08 | $105.00M 10-Q · filed 2016-08-08 | $136.00M derived: sum of 3 quarters · filed 2016-08-08 | $143.00M derived: sum of 4 quarters · filed 2016-08-08 | |
| 2015-03-31 | $53.00M 10-Q · filed 2016-05-09 | $84.00M derived: sum of 2 quarters · filed 2016-05-09 | $91.00M derived: sum of 3 quarters · filed 2016-05-09 | $79.00M derived: sum of 4 quarters · filed 2016-05-09 | |
| 2014-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $38.00M derived: sum of 2 quarters · filed 2016-02-26 | $26.00M derived: sum of 3 quarters · filed 2016-02-26 | $24.00M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $7.00M 10-Q · filed 2015-11-05 | -$5.00M derived: sum of 2 quarters · filed 2015-11-05 | -$7.00M 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | -$12.00M 10-Q · filed 2015-08-06 | -$14.00M 10-Q · filed 2015-08-06 | |||
| 2013-12-31 | -$86.00M 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |